Shenzhenshi Yimaitong Techenology Co., Ltd. – Trademark Portfolio

Entity Type: 16

Shenzhenshi Yimaitong Techenology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include YMT LIFE. The owner is based in Shenzhen.

2nd Floor, Building North One, Dankeng R

Guanlan Street, Longgang District

Shenzhen 518110 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

YMT LIFE
YMT LIFE
Registered 2019

Trademark Classifications

Shenzhenshi Yimaitong Techenology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Shenzhenshi Yimaitong Techenology Co., Ltd. have?

Shenzhenshi Yimaitong Techenology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shenzhenshi Yimaitong Techenology Co., Ltd. file in?

Shenzhenshi Yimaitong Techenology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Shenzhenshi Yimaitong Techenology Co., Ltd.'s most well-known trademarks?

Shenzhenshi Yimaitong Techenology Co., Ltd.'s registered trademark portfolio includes well-known marks such as YMT LIFE. These are among 1 currently registered trademark in the portfolio.

What is Shenzhenshi Yimaitong Techenology Co., Ltd.'s trademark registration success rate?

Shenzhenshi Yimaitong Techenology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.